BKI-1748 confers a high level of protection against ovine congenital toxoplasmosis when administered after IgM seroconversion

BackgroundUnlike mouse models of congenital toxoplasmosis, pregnant sheep models provide the opportunity to evaluate treatment strategies that more closely resemble clinical practice in pregnant women, including chemotherapeutic interventions initiated after specific IgM seroconversion. BKI-1748, wh...

Cijeli opis

Bibliografski detalji

Glavni autori:	Roberto Sánchez-Sánchez, Natalia Velasco-Jiménez, David Arranz-Solís, Miguel Criado, Ignacio Ferre, Michela Re, Matthew A. Hulverson, Ryan Choi, Lynn K. Barrett, Andrew Hemphill, Wesley C. Van Voorhis, Luis Miguel Ortega-Mora
Format:	Artigo
Jezik:	Inglês
Izdano:	Frontiers Media S.A. 2026-04-01
Serija:	Frontiers in Cellular and Infection Microbiology
Teme:	BKI-1748 congenital toxoplasmosis efficacy IgM sheep Toxoplasma gondii
Online pristup:	https://www.frontiersin.org/articles/10.3389/fcimb.2026.1819490/full
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!